Jump to the main content block
  1. Home

Faculty

 

Faculty

 

Liu, I-Min /Professor

 

Dean of the College of pharmacy&Health care

chairman of Department of Pharmacy and Master Program

Email address:iml@tajen.edu.tw

Contact number: 08-7624002#3000

 

Journal Papers

 

  1.  Lai MC, Liu WY, Tzeng YC, Liu IM* (2025 Sep). Protective Effects of Coixol Against Nε-Carboxymethyllysine-Induced Injury in IMR-32 Neuronal Cells: Modulation of Endoplasmic Reticulum Stress and Amyloidogenic Pathways. Nutrients, 17(18):2939. *本人為通訊作者.
  2. Liu YS, Lai MC, Hong TY, Liu IM* (2025 Feb).γ-Oryzanol: A nutrient-rich ingredient for promoting wound healing. Heliyon, 11(4):e42551. *本人為通訊作者.
  3. Liu YS, Lai MC, Tzeng YC, Liu IM* (2025 Jan). Polyphenolic Hispolon Derived from Medicinal Mushrooms of the Inonotus and Phellinus Genera Promotes Wound Healing in Hyperglycemia-Induced Impairments. Nutrients, 17(2):266. *本人為通訊作者.
  4. Jean SS, Ko WC, Liu IM, Hsieh PC, Hsueh PR (2024 Dec). Geographic differences in susceptibility profiles of potential non-class B carbapenemase-producing Enterobacterales isolates against ceftazidime-avibactam, meropenem-vaborbactam, colistin, amikacin, gentamicin, and tigecycline: Data from the antimicrobial testing leadership and surveillance, 2018-2022. International Journal of Antimicrobial Agents, 64(6), 107363.
  5. Jean SS, Liu CY, Huang TY, Lai CC, Liu IM, Hsieh PC, Hsueh PR (2024 Dec). Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future? Expert Review of Anti-infective Therapy, 22(12), 1171-1187.
  6. Kuo LK, Chang HT, Hsueh SC, Liu IM, Hsieh PC, Jean SS (2024 Oct). Bacterial profile, and independent predictors for healthcare-associated pneumonia persistently caused by multidrug-resistant Gram-negative bacteria for patients with the preceding multidrug-resistant Gram-negative pneumonia in Taiwan. Journal of Microbiology, Immunology, and Infection, 57(5), 801-811.
  7. Liu YS, Lai MC, Hong TY, Liu IM* (2024 Sep). Exploring the Wound Healing Potential of Hispidin. Nutrients,16(18), 3161. *本人為通訊作者.
  8. Chen LC, Lai MC, Hong TY, Liu IM* (2024 Apr). γ-Oryzanol from Rice Bran Antagonizes Glutamate-Induced Excitotoxicity in an In Vitro Model of Differentiated HT-22 Cells. Nutrients, 16(8), 1237. *本人為通訊作者.
  9. Hsueh SC, Huang YT, Ko WC, Liu IM, Hsieh PC, Jean SS (2024 Mar). In vitro antimicrobial susceptibility data of global meropenem-resistant Acinetobacter baumannii isolates causing pneumonia: Data from the Antimicrobial Testing Leadership and Surveillance Program, 2014-2021, and re-estimations of susceptibility breakpoints and appropriate dosages of important antibiotics for pneumonia treatment. Journal of Global Antimicrobial Resistance, 36, 411-418.
  10. Jean SS, Liu CY, Huang YT, Ko WC, Ho MW, Liu IM, Hsieh PC, Hsueh PR (2024 Mar). Minimum inhibitory concentrations of antifungals against invasive isolates of Cryptococcus species worldwide: Global antifungal antimicrobial testing leadership and surveillance program, 2010-2020. International Journal of Antimicrobial Agents, 63(3), 107090.
  11. Li Y, Cheng KC, Liu IM, Cheng JT (2023 Oct). Identification of andrographolide as an agonist of bile acid TGR5 receptor in a cell line to demonstrate the reduction in hyperglycemia in Type-1 diabetic rats. Pharmaceuticals (Basel),16(10), 1417.
  12. Hsueh PR, Ho SJ, Hsieh PC, Liu IM, Jean SS (2023 Aug). Use of multiple doses of intravenous infusion of umbilical cord-mesenchymal stem cells for the treatment of adult patients with severe COVID-19-related acute respiratory distress syndrome: literature review. Stem Cells International, 2023, 7179592.
  13. Jean SS, Liu IM, Hsieh PC, Kuo DH, Liu YL, Hsueh PR (2023 May). Off-label use versus formal recommendations of conventional and novel antibiotics for the treatment of infections caused by multidrug-resistant bacteria. International Journal of Antimicrobial Agents, 61(5), 106763.
  14. Lai MC, Liu WY, Liou SS, Liu IM* (2023 Jan). Hispidin in the medicinal fungus protects dopaminergic neurons from JNK activation-regulated mitochondrial-dependent apoptosis in an MPP+-induced in vitro model of Parkinson's disease. Nutrients, 15(3), 549. *本人為通訊作者.
  15. Cheng JT, Liu IM, Shen SC (2022 Oct). Plant therapeutics. Plants (Basel), 11(20):2720.
  16. Lai MC, Liu WY, Liou SS, Liu IM* (2022 Nov). p-Hydroxybenzyl alcohol antagonized the ROS-dependent JNK/Jun/Caspase-3 pathway to produce neuroprotection in a cellular model of Parkinson's disease. Nutrients, 14(23), 5002. *本人為通訊作者.
  17. Lai MC, Liu WY, Liou SS, Liu IM* (2022 May). Diosmetin targeted at peroxisome proliferator-activated receptor gamma alleviates advanced glycation end products induced neuronal injury. Nutrients, 14(11), 2248. *本人為通訊作者.
  18. Lai MC, Liu WY, Liou SS, Liu IM* (2022 Feb). The citrus flavonoid hesperetin encounters diabetes-mediated Alzheimer-type neuropathologic changes through relieving advanced glycation end-products inducing endoplasmic reticulum stress. Nutrients, 14(4):745. *本人為通訊作者.
  19. Li YX, Cheng KC, Liu IM, Niu HS* (2022 Jan) Myricetin increases circulating adropin level after activation of glucagon-like peptide 1 (GLP-1) receptor in type-1 diabetic rats. Pharmaceuticals (Basel),15,173.

 

Patent

  1. 劉怡旻;張家茹;劉崇喜，“A ginger extract for inhibiting the fat-storage funvtion of adipocytes”， 美國發明專利，已核准證書字號：US 8,501,249 B2
  2. 劉崇喜;劉怡旻;張家茹;唐偉智，“Herbal preparation for anemia and a manufacture method thereof”， 美國發明專利，已核准證書字號：US 8,420,136 B2
  3. 劉崇喜;劉怡旻;李瑞瑜，『從山藥塊根外皮萃取抗氧化物質之製備方法』，中華民國發明專利，已核准證書字號：I379687，2012.12.21 ~ 2029.9.8。
  4. 劉怡旻;劉崇喜;張家茹，『薄荷抗氧化物質之恆溫萃取法』，中華民國發明專利，已核准證書字號：I361097，2012.4.1~2029.8.30。
  5. 劉崇喜;劉怡旻，『中藥當歸之定量定溫及定時炮製法』，中華民國發明專利，已核准證書字號：I339123，2011.3.21~2027.9.6。

 

 

Click Num:
Print
Login Success